July 28, 2014 3:27 PM ET

Biotechnology

Company Overview of CancerVax Corp.

Company Overview

As of May 5, 2006, CancerVax Corporation was acquired by Micromet, Inc. in a reverse merger transaction. CancerVax Corporation, a biotechnology company, engages in the research, development, and commercialization of biological products for the treatment and control of cancer. The company provides D93, an antiangiogenic, humanized, and monoclonal antibody, for patients with solid tumors. It also develops products that target the epidermal growth factor (EGF) receptor signaling pathway, which include SAI-EGF for the treatment of nonsmall-cell lung cancer; SAI-TGF-á, an investigational product candidate that stimulates the immune system to develop anti-TGF-á antibodies; and SAI-EGFR-ECD, an inv...

2110 Rutherford Road

Carlsbad, CA 92008

United States

Founded in 1998

52 Employees

Phone:

760-494-4200

Fax:

760-431-9980

Key Executives for CancerVax Corp.

CancerVax Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Garnet Biotherapeutics, Inc. United States
Taxon Biosciences, Inc. United States
Sierra Diagnostics Inc United States
Exosome Diagnostics, Inc. United States
Qwell Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CancerVax Corp., please visit www.cancervax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.